A neuroscientist has raised concerns about medicine development. The issue affects how drugs work and their side effects. African populations are underrepresented in research and testing, which determines these factors. This underrepresentation can leave patients exposed to treatments with unknown effects.

The problem is not limited to one area of research. It extends to the broader development of medicines. Further details about this issue are available from the source.

African patients may be consuming medicines that are not fully understood in terms of their effects on the continent's population.